Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density
Objective: The purpose of this study was to determine whether estrogen supplementation primarily from oral contraceptive pills compared to no estrogen supplementation is associated with differences in mean bone mineral density (BMD) measured by DXA in a cross-sectional study of women with cystic fib...
Main Authors: | Malinda Wu, William R. Hunt, Melissa S. Putman, Vin Tangpricha |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Journal of Clinical & Translational Endocrinology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214623719301541 |
Similar Items
-
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease
by: Malinda Wu, et al.
Published: (2021-08-01) -
Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis
by: Malinda Wu, et al.
Published: (2022-03-01) -
Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020-02-01) -
Comparison of Metformin and Ethinyl Estradiol-Cyproterone Acetate in the Management of Polycystic Ovary Syndrome
by: Sadaf Ajaib, et al.
Published: (2018-09-01) -
Estradiol, Estrone and Ethinyl Estradiol Metabolism Studied by High Resolution LC-MS/MS Using Stable Isotope Labeling and Trapping of Reactive Metabolites
by: Kahina Chabi, et al.
Published: (2022-09-01)